| | | | | | | | | | |
|
| |
|
| Dockets Entered
On September 21, 2006
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006D-0331
|
| Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
|
|
|
|
|
| 2006M-0389
|
| P050042 - ARCHITECT Anti-HCV Assay; ARCHITECT Anti-HCV Calibrator and ARCHITECT Anti-HCV Control
|
|
|
|
|
|
|
| FDA-Regulated Products Containing Nanotechnology Materials
|
|
|
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
|
|
|
|
| 2006P-0223
|
| Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| C 18137
|
| D. Cole
|
| Vol #:
|
| 196
|
|
|
|
|
| C 18138
|
| K. Rutherford
|
| Vol #:
|
| 196
|
|
|
|
|
| 2006D-0331
|
| Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
|
|
|
|
|
| EC 27
|
| U.S. Metropolitan Emerg Med Svcs Medical Directors
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 28
|
| Novo Nordisk Inc
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 29
|
| Department of Emergency Medicine, Univ.of Michigan
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 30
|
| Mrs. Sandra Sells
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 31
|
| American Heart Association/American Stroke Associa
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 32
|
| Neurological Emergencies Treatment Trials network
|
| Vol #:
|
| 1
|
|
| |
|
| 2006M-0389
|
| P050042 - ARCHITECT Anti-HCV Assay; ARCHITECT Anti-HCV Calibrator and ARCHITECT Anti-HCV Control
|
|
|
|
|
| AAV 1
|
| Abbott Laboratories
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0107
|
| FDA-Regulated Products Containing Nanotechnology Materials
|
|
|
|
|
| EC 8
|
| Mr. Tim Welch
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
|
|
|
|
| EC 64
|
| Mr. Stephen Davidson
|
| Vol #:
|
| 3
|
|
|
|
|
| 2006P-0223
|
| Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
|
|
|
|
|
|
|
|
|
| EC 706
|
| Miss. TRACEY GOGGINS
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 707
|
| Ms. Sandra Blackburn
|
| Vol #:
|
| 5
|
|
